Smoking Cessation Drug Tied to Increased Cardiovascular Risk
Varenicline associated with increased incidence of CV events in first 12 weeks after receipt of drug
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Cardiology, Family Medicine, Gynecology, Internal Medicine, Neurology, Nursing, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news
More News: Brain | Cardiology | Cardiovascular | Chantix | Heart | Internal Medicine | Neurology | Nurses | Nursing | Psychiatry | Smokers